Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Focal adhesion signaling components represent a complex network of proteins that facilitate communication between the extracellular matrix (ECM) and the cell's interior (Parsons et al., 2010). This signaling hub is initiated by the clustering of integrin receptors upon ECM binding, which subsequently recruits structural proteins like vinculin and talin, as well as signaling enzymes such as Focal Adhesion Kinase (FAK) and Src (Hynes, 2002). These components integrate mechanical and chemical signals to regulate essential cellular behaviors, including migration, survival, and cell cycle progression through the activation of downstream cascades like PI3K/Akt and MAPK/ERK (Sulzmaier et al., 2014). In the context of disease, particularly malignancy, dysregulation of focal adhesion signaling is a hallmark of the epithelial-to-mesenchymal transition (EMT), driving tumor cell invasion and metastasis (Tai et al., 2015). Therapeutic strategies often focus on inhibiting specific enzymatic components like FAK or Src to suppress these pro-tumorigenic signals and overcome chemoresistance, with several inhibitors such as defactinib and dasatinib undergoing clinical evaluation (Infante et al., 2015).
Inhibition of Focal Adhesion Kinase (FAK) autophosphorylation at Tyr397, inhibition of Src family kinase activity, and competitive blockade of integrin-extracellular matrix ligand binding to disrupt downstream PI3K/Akt and MAPK/ERK signaling pathways.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Focal adhesion signaling components (FA signaling).